Estimaciones de analistas de Wall Street para Corbus Pharmaceuticals Holdings, Inc. (CRBP): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 1.40 |
| EV / EBITDA | -1.84 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.9M | $2.4M | $4.8M | $36.1M | $3.9M | $881705 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $15.4M | $26.0M | $48.6M | $89.6M | 0 | $1.6M | $1.5M | 0 | $600000 | 0 |
| Beneficio Bruto | -$13.5M | -$23.6M | -$43.8M | -$53.5M | $3.9M | -$757527 | -$1.5M | 0 | -$600000 | 0 |
| I+D | $15.4M | $26.0M | $48.6M | $89.6M | $98.3M | $36.4M | $16.1M | $31.2M | $32.2M | $70.1M |
| Generales y Administrativos | $6.5M | $9.0M | $13.0M | $23.6M | $28.5M | $20.4M | $18.7M | $13.9M | $16.5M | $15.2M |
| Gastos Operativos | $21.9M | $35.0M | $61.6M | $23.6M | $126.7M | $55.2M | $33.3M | $45.1M | $48.1M | $85.3M |
| Beneficio Operativo | -$20.0M | -$32.6M | -$56.7M | -$77.1M | -$122.8M | -$56.0M | -$34.8M | -$45.1M | -$48.7M | -$85.3M |
| EBITDA | -$19.9M | -$32.3M | -$56.3M | -$76.4M | -$121.1M | -$42.2M | -$38.7M | -$40.1M | -$37.7M | -$78.3M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $1.0M | $1.8M | $2.1M | $2.9M | $1.9M | 0 |
| Beneficio Antes de Impuestos | -$20.0M | -$32.4M | -$55.7M | -$71.5M | -$111.3M | -$45.6M | -$42.3M | -$44.6M | -$40.2M | -$78.5M |
| Impuestos | $13617 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$20.0M | -$32.4M | -$55.7M | -$71.5M | -$111.3M | -$45.6M | -$55.8M | -$44.6M | -$40.2M | -$78.5M |
| BPA | $-14.58 | $-19.38 | $-29.30 | $-33.55 | $-42.72 | $-11.13 | $-10.15 | $-10.31 | $-3.68 | $-5.90 |
| BPA Diluido | $-14.58 | $-19.38 | $-29.30 | $-33.55 | $-42.72 | $-11.13 | $-10.15 | $-10.31 | $-3.68 | $-5.90 |
| Acciones en Circulación (Diluidas) | $1.4M | $1.7M | $1.9M | $2.1M | $2.6M | $4.1M | $4.2M | $4.3M | $10.9M | $13.3M |
Precio
| Precio | $7.26 |
| Capitalización | $135M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ALEC · APLT · CRDF · ELTX · FBRX · IPHA · MIST
Explorar sector: Healthcare · Biotechnology
Más secciones de CRBP: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones